-
Product Insights
Squamous Non-Small Cell Lung Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Squamous Non-Small Cell Lung Cancer - Drugs In Development, 2023’, provides an overview of the Squamous Non-Small Cell Lung Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Squamous Non-Small Cell Lung Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CDK-002 in Triple-Negative Breast Cancer (TNBC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. CDK-002 in Triple-Negative Breast Cancer (TNBC) Drug Details: CDK-002Â is under development for the treatment of...
-
Product Insights
NewVentilators Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ventilators Pipeline Market Report Overview A ventilator is an artificial respiratory support device. It uses air pressure to deliver air into the lungs and alternatively, creates vacuum pressure to release carbon dioxide from it. The ventilators pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials,...
-
Product Insights
Mtkvari Cascade 4
Mtkvari Cascade 4 is a Hydro project located in Kvemo Kartli, Georgia. The project is owned by VM Electric and is developed by Gross Energy Group LLC; VM Electric. The project is at the permitting stage. Empower your strategies with our Mtkvari Cascade 4 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Donaperminogene Seltoplasmid in Diabetic Neuropathic Pain
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Donaperminogene seltoplasmid in Diabetic Neuropathic Pain Drug Details: Donaperminogene seltoplasmid (VM-202) is under development...
-
Product Insights
Los Guajares
Los Guajares is a hydro project located in Andalusia, Spain. The project is owned and being developed by Energya VM Gestion de Energia S.L.. The project is expected to come online in 2029. Empower your strategies with our Los Guajares report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Depulfavirine in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Depulfavirine in Human Immunodeficiency Virus (HIV) Infections (AIDS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Depulfavirine in Human Immunodeficiency Virus (HIV) Infections...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Foslinanib in Multiple Myeloma (Kahler Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Foslinanib in Multiple Myeloma (Kahler Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Foslinanib in Multiple Myeloma (Kahler Disease) Drug Details: Foslinanib (TRX-818)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Estradiol + Progesterone) in Vasomotor Symptoms of Menopause (Hot Flashes)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.(Estradiol + Progesterone) in Vasomotor Symptoms of Menopause (Hot Flashes) Drug Details:Estradiol in combination with progesterone...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Foslinanib in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Foslinanib in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Foslinanib in Solid Tumor Drug Details:Foslinanib (TRX-818) is under development for the treatment...